Overview

Latin America In Vitro Diagnostics (IVD) Market is poised to value over USD 6.1 billion by 2027 end at a CAGR of over 7.7% during the forecast period 2020 to 2027

FutureWise Market Research has instantiated a report that provides an intricate analysis of Latin America In Vitro Diagnostics (IVD) Market  trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Latin America In Vitro Diagnostics (IVD) Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

Major players included in the Latin America In Vitro Diagnostics (IVD) Market:
• Roche Diagnostics (Switzerland)
• Siemens Healthcare GmbH (Germany)
• Qiagen N.V (Germany)
• Biomérieux S.A. (France)
• Abbott Laboratories (U.S.)
• Becton, Dickinson And Company (U.S.)
• Bio-Rad Laboratories, Inc. (U.S.)
• Wama Diagnóstica (Brazil)
• Labin Perú S.A. (Peru)
• WM Argentina SA (Argentina)
• Belomed SRL (Peru)
• Wiener Laboratorios SAIC (Argentina)
• Diagnóstica Peruana SAC (Peru)
• Diamed Argentina (Argentina)
• Andina Medica (Peru)
• Grifols Chile S.A (Chile).
(Note: The list of the major players will be updated with the latest market scenario and trends)

Latin America In Vitro Diagnostics (IVD) Market Segmentation:
By Product
• Reagents, Assays, and Kits
• Instruments/Analyzers
• Software and Services

By Technology
• Immunoassay/Immunochemistry
 o Enzyme-Linked Immunosorbent Assay (ELISA)
 o Radioimmunoassay
 o Rapid Tests
 o Western Blotting
 o Other Immunochemistry Tests
• Clinical Chemistry
 o Metabolic Panel
 o Electrolyte Panel
 o Liver Panel
 o Lipid Profile
 o Renal Profile
 o Thyroid Function Panel
• Molecular Diagnostics
 o Polymerase Chain Reaction (PCR)
 o Isothermal Nucleic Acid Amplification Technology (INAAT)
 o Microarrays
 o DNA Sequencing & Next-Generation Sequencing
 o Other Molecular Diagnostic Tests
• Microbiology
• Hematology
• Coagulation & Hemostasis
• Urinalysis
• Other IVD Technologies

By Application
• Infectious Diseases
• Oncology
• Endocrinology
• Diabetes
• Cardiology
• Other Applications

By End User
• Hospital Laboratories
• Diagnostic Reference Laboratories
• Point-of-Care (POC) Testing
• Academic & Research Institutes

By Region
• Brazil
• Venezuela
• Argentina
• Rest of Latin America

Competitive Landscape:
• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

FutureWise Key Takeaways:
• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

Objectives of the Study:
• To provide with an exhaustive analysis on the Latin America In Vitro Diagnostics (IVD) Market By Product, By Technology, By Application, By End User and By Region.
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— Brazil, Venezuela, Argentina, Rest of Latin America
• To record and evaluate competitive landscape mapping- Product launches, technological advancements, mergers and expansions

Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization Mobility Care offered are free of charge with purchase of any license of the report
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents

1. Market Introduction
  1.1 Objectives of the Study
  1.2 Market Definition
  1.3 Market Scope
      1.3.1 Years Considered for the Study
      1.3.2 Market Covered
  1.4 Currency
  1.5 Limitations
  1.6 Stakeholders

2. Research Methodology
   2.1 Research Data
       2.1.1 Secondary Data
             2.1.1.1 Key Data from Secondary Sources
       2.1.2 Primary Data
             2.1.2.1 Key Data from Primary Sources
   2.2 Market Size Estimation
   2.3 Market Breakdown and Data Triangulation
   2.4 Assumptions for the Study  

3. Executive Summary
  3.1 Market Outlook
  3.2 Segment Outlook
  3.3 Competitive Insights

4. Global Latin America In Vitro Diagnostics (IVD) Market Variables, Trends & Scope
  4.1. Market Lineage Outlook
  4.2. Penetration and Growth Prospect Mapping
  4.3. Industry Value Chain Analysis
  4.4. Cost Analysis Breakdown
  4.5. Technology Overview
  4.6. Regulatory Framework
       4.6.1. Reimbursement Framework
       4.6.2. Standards and Compliances

5. Market Overview
  5.1. Market Dynamics
       5.1.1. Market Driver Analysis
              5.1.1.1. Increasing focus of Latin America In Vitro Diagnostics (IVD) Market Companies on Brand Protection
              5.1.1.2. Untapped Opportunities in Emerging Regions
       5.1.2. Market Restraint Analysis
              5.1.2.1. High Cost Associated with Implementation of Predictive Analysis
       5.1.3. Industry Challenges
              5.1.3.1. Presence of Ambiguous Regulatory Framework

6. Latin America In Vitro Diagnostics (IVD) Market Analysis Tools
  6.1. Industry Analysis - Porter’s
       6.1.1. Supplier Power
       6.1.2. Buyer Power
       6.1.3. Substitution Threat
       6.1.4. Threat from New Entrants
       6.1.5. Competitive Rivalry
  6.2. Pestel Analysis
       6.2.1. Political Landscape
       6.2.2. Environmental Landscape
       6.2.3. Social Landscape
       6.2.4. Technology Landscape
       6.2.5. Legal Landscape
  6.3. Major Deals And Strategic Alliances Analysis
       6.3.1. Joint Ventures
       6.3.2. Mergers and Acquisitions
       6.3.3. Licensing and Partnership
       6.3.4. Technology Collaborations
       6.3.5. Strategic Divestments
  6.4. Market Entry Strategies
  6.5. Case Studies

7. Latin America In Vitro Diagnostics (IVD) Market, By Product Historical Analysis and Forecast 2020-2027 (USD Million)
   7.1. Reagents, Assays, and Kits
   7.2. Instruments/Analyzers
   7.3. Software and Services

8. Latin America In Vitro Diagnostics (IVD) Market, By Technology  Historical Analysis and Forecast 2020-2028 (USD Million)
  8.1. Immunoassay/Immunochemistry
       8.1.1. Enzyme-Linked Immunosorbent Assay (ELISA)
       8.1.2. Radioimmunoassay
       8.1.3. Rapid Tests
       8.1.4. Western Blotting
       8.1.5. Other Immunochemistry Tests
  8.2. Clinical Chemistry
       8.2.1. Metabolic Panel
       8.2.2. Electrolyte Panel
       8.2.3. Liver Panel
       8.2.4. Lipid Profile
       8.2.5. Renal Profile
       8.2.6. Thyroid Function Panel
  8.3. Molecular Diagnostics
       8.3.1. Polymerase Chain Reaction (PCR)
       8.3.2. Isothermal Nucleic Acid Amplification Technology (INAAT)
       8.3.3. Microarrays
       8.3.4. DNA Sequencing & Next-Generation Sequencing
       8.3.5. Other Molecular Diagnostic Tests
  8.4. Microbiology
  8.5. Hematology
  8.6. Coagulation & Hemostasis
  8.8. Urinalysis
  8.8. Other IVD Technologies

9. Latin America In Vitro Diagnostics (IVD) Market, By Application Historical Analysis and Forecast 2020-2027 (USD Million)
  9.1. Infectious Diseases
  9.2. Oncology
  9.3. Endocrinology
  9.4. Diabetes
  9.5. Cardiology
  9.5. Other Applications

10. Latin America In Vitro Diagnostics (IVD) Market, By End User Historical Analysis and Forecast 2020-2027 (USD Million)
  10.1. Mastectomy
  10.2. Lumpectomy
  10.3. Plastic Surgery
  10.4. Breast Reconstruction

11. Latin America In Vitro Diagnostics (IVD) Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
   11.1. Introduction
   11.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
         11.2.1. Brazil
         11.2.2. Venezuela
         11.2.3. Argentina
         11.2.4. Rest of Latin America
   11.3. Market Size (USD Million) Forecast for Latin America 2020-2027

12. Market Share Analysis and Competitive Landscape  
   12.1. Latin America Landscape - Key Players, Revenue and Presence
   12.2. Latin America Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
   12.3. Latin America Emerging Companies
   12.4. Latin America - Market Share Analysis and Key Regional Players
   12.5. Latin America Key Player - Growth Matrix

13. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
   13.1. Roche Diagnostics (Switzerland)
         13.1.1. Company Overview
         13.1.2. Product Portfolio
         13.1.3. SWOT Analysis
         13.1.4. Financial Overview
         13.1.5. Strategic Overview
   13.2. Siemens Healthcare GmbH (Germany)
         13.2.1. Company Overview
         13.2.2. Product Portfolio
         13.2.3. SWOT Analysis
         13.2.4. Financial Overview
         13.2.5. Strategic Overview
   13.3. Qiagen N.V (Germany)
         13.3.1. Company Overview
         13.3.2. Product Portfolio
         13.3.3. SWOT Analysis
         13.3.4. Financial Overview
         13.3.5. Strategic Overview
   13.4. Biomérieux S.A. (France)
         13.4.1. Company Overview
         13.4.2. Product Portfolio
         13.4.3. SWOT Analysis
         13.4.4. Financial Overview
         13.4.5. Strategic Overview
   13.5. Abbott Laboratories (U.S.)
         13.5.1. Company Overview
         13.5.2. Product Portfolio
         13.5.3. SWOT Analysis
         13.5.4. Financial Overview
         13.5.5. Strategic Overview          
   13.6. Becton, Dickinson And Company (U.S.)
         13.6.1. Company Overview
         13.6.2. Product Portfolio
         13.6.3. SWOT Analysis
         13.6.4. Financial Overview
         13.6.5. Strategic Overview      
   13.7. Bio-Rad Laboratories, Inc. (U.S.)
         13.7.1. Company Overview
         13.7.2. Product Portfolio
         13.7.3. SWOT Analysis
         13.7.4. Financial Overview
         13.7.5. Strategic Overview
   13.8. Wama Diagnóstica (Brazil)
         13.8.1. Company Overview
         13.8.2. Product Portfolio
         13.8.3. SWOT Analysis
         13.8.4. Financial Overview
         13.8.5. Strategic Overview
   13.9. Labin Perú S.A. (Peru)
         13.9.1. Company Overview
         13.9.2. Product Portfolio
         13.9.3. SWOT Analysis
         13.9.4. Financial Overview
         13.9.5. Strategic Overview
   13.10.WM Argentina SA (Argentina)
         13.10.1.Company Overview
         13.10.2.Product Portfolio
         13.10.3.SWOT Analysis
         13.10.4.Financial Overview
         13.10.5.Strategic Overview
   13.11.Belomed SRL (Peru)
         13.11.1.Company Overview
         13.11.2.Product Portfolio
         13.11.3.SWOT Analysis
         13.11.4.Financial Overview
         13.11.5.Strategic Overview
   13.12.Wiener Laboratorios SAIC (Argentina)
         13.12.1.Company Overview
         13.12.2.Product Portfolio
         13.12.3.SWOT Analysis
         13.12.4.Financial Overview
         13.12.5.Strategic Overview
   13.13.Diagnóstica Peruana SAC (Peru)
         13.13.1.Company Overview
         13.13.2.Product Portfolio
         13.13.3.SWOT Analysis
         13.13.4.Financial Overview
         13.13.5.Strategic Overview
   13.14.Diamed Argentina (Argentina)
         13.14.1.Company Overview
         13.14.2.Product Portfolio
         13.14.3.SWOT Analysis
         13.14.4.Financial Overview
         13.14.5.Strategic Overview
   13.15.Andina Medica (Peru)
         13.15.1.Company Overview
         13.15.2.Product Portfolio
         13.15.3.SWOT Analysis
         13.15.4.Financial Overview
         13.15.5.Strategic Overview
   13.16.Grifols Chile S.A (Chile).
         13.16.1.Company Overview
         13.16.2.Product Portfolio
         13.16.3.SWOT Analysis
         13.16.4.Financial Overview
         13.16.5.Strategic Overview

14. Pre and Post COVID-19 Impact
   14.1. Positive influence on the healthcare industry
   14.2. The financial disruption of the manufacturing sector
   14.3. Impact of COVID-19 on emerging companies
   14.4. Significant mandates in the healthcare regulations initiated by administrations
   14.5. The overall economic slowdown of the developing and developed nations

15. FutureWise SME Key Takeaway Points for Client

Tables

Figures